Zobrazeno 1 - 10
of 15
pro vyhledávání: '"J A, Mattis"'
Autor:
J N Mattis, Eric T Olson
The Multi-Service Concept for Irregular Warfare broadly describes how future US military forces will conduct irregular warfare in support of unified action on a regional or global scale against both state and non-state adversaries. It is meant as a g
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ccf1bd0e6f2722d39278f932210fc46e
https://doi.org/10.21236/ada454228
https://doi.org/10.21236/ada454228
This publication is designed for use at the tactical and operational levels. This manual provides multiservice tactics, techniques, and procedures (MTTP) for chemical, biological, radiological, and nuclear (CBRN) decontamination. It defines the roles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ef8907e3593d82f155d97fd8f382d390
https://doi.org/10.21236/ada523781
https://doi.org/10.21236/ada523781
SCOPE: This multi-service operations publication provides tactics, techniques, and procedures (TTP) for conducting chemical, biological, radiological, and nuclear (CBRN) avoidance. This document presents comprehensive TTP for passive and active avoid
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0b1f4dbcb60d4c6350afd1e6bf856f78
https://doi.org/10.21236/ada450748
https://doi.org/10.21236/ada450748
Autor:
D J, Hnatowich, M, Rusckowski, D A, Siebecker, M, Gionet, G, Mardirossian, H S, Bushe, S, Roy, J A, Mattis, D, Shealy, T W, Griffin
Publikováno v:
Journal of nuclear biology and medicine (Turin, Italy : 1991). 36(1)
In a program to investigate patient pharmacokinetics of labeled anti-tumor antibodies, a study of the 10-3D2 anti-breast tumor antibody was conducted. The F(ab')2 fragment, coupled with DTPA, was radiolabeled with indium-111 and 1 mg (37 MBq, or 1 mC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5f25c31f13db9586dd3098da8d7a758f
https://pubmed.ncbi.nlm.nih.gov/1450229
https://pubmed.ncbi.nlm.nih.gov/1450229
Autor:
K Y, Pak, M A, Nedelman, M, Kanke, B A, Khaw, J A, Mattis, H W, Strauss, R T, Dean, H J, Berger
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 33(1)
An instant kit method for labeling antibody Fab' fragments was developed. The method utilizes a ligand exchange reaction between the intermediate complex 99mTc-D-glucarate and the free sulfhydryl groups on the antibody Fab' fragment. Radiolabeling of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::5c79b223c3d7cef78711467107e73d6d
https://pubmed.ncbi.nlm.nih.gov/1730981
https://pubmed.ncbi.nlm.nih.gov/1730981
Publikováno v:
Journal of Biological Chemistry. 252:6776-6782
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8ec5d1695d7174073599baac067fcddd
https://doi.org/10.1016/s0021-9258(17)39917-9
https://doi.org/10.1016/s0021-9258(17)39917-9
Autor:
D J, Hnatowich, T W, Griffin, C, Kosciuczyk, M, Rusckowski, R L, Childs, J A, Mattis, D, Shealy, P W, Doherty
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 26(8)
We have evaluated the pharmacokinetics in patients of a monoclonal antibody (19-9) F(ab')2 fragment coupled with DTPA and labeled with 111In. In addition to imaging and organ uptake determinations, serum and urine samples were analyzed to help determ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f9e2c5148270e48ac812bc3d30dc8966
https://pubmed.ncbi.nlm.nih.gov/3861793
https://pubmed.ncbi.nlm.nih.gov/3861793
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 29(4)
Monoclonal antibody 59D8 developed by Hui et al., binds to fibrin but not fibrinogen. An 111In-labeled Fab fragment of 59D8 was studied in vitro and in animal models to evaluate its potential for imaging thrombi and emboli in man. Rabbits and dogs we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ddeaa6e1cfdd1d9f517f7e1e6eae4323
https://pubmed.ncbi.nlm.nih.gov/3351604
https://pubmed.ncbi.nlm.nih.gov/3351604
Pharmacokinetics of 111In-labeled OC-125 antibody in cancer patients compared with the 19-9 antibody
Autor:
D J, Hnatowich, M, Gionet, M, Rusckowski, D A, Siebecker, J, Roche, D, Shealy, J A, Mattis, J, Wilson, J, McGann, R E, Hunter
Publikováno v:
Cancer research. 47(22)
We recently reported on the pharmacokinetics in 14 cancer patients of the 19-9 antibody radiolabeled with 111In. We have now repeated this investigation in 18 cancer patients using the OC-125 antibody, in part to compare the in vivo behavior of two m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::35ecd8df7f54040fdddfd857b1c00e1c
https://pubmed.ncbi.nlm.nih.gov/3664510
https://pubmed.ncbi.nlm.nih.gov/3664510
Publikováno v:
Cancer research. 43(6)
Mouse IgG2a monoclonal antibodies with specific binding reactivity in vitro to human tumors of the gastrointestinal tract were radioiodinated and injected into immunosuppressed mice xenografted with human colon carcinoma tumors. The antibodies prefer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::079c25332d5716cce36964115d1e89a1
https://pubmed.ncbi.nlm.nih.gov/6342757
https://pubmed.ncbi.nlm.nih.gov/6342757